PHAR
Pharming Group·NASDAQ
--
--(--)
--
--(--)
PHAR Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-06
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
2025-11-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-06 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
